Miniaturize Experiments.
Maximize Discovery.
Our platform redefines lab automation—enabling high-throughput, low-volume workflows that turn precious patient samples into rich, high-dimensional datasets—accelerating genomic discovery and powering the future of personalized medicine.
Smaller Volumes
Bigger Impact
In a RNP-based editing experiments, we achieve high-efficiency knockout using nanoliter volumes and dramatically reduced cell input, making arrayed CRISPR screening in precious immune samples feasible.
1 CRISPR KO edit in primary T cells needs:
10,000
1,000,000
Others
Real results:
Big Savings,
Bigger Possibilities
DropGenie doesn’t just save time and money—it makes the impossible possible.
GET EARLY ACCESS
Case Study:
Arrayed CRISPR screen in immune cells
The DropGenie Advantage
DropGenie has perfected the miniaturization and parallelization of cell engineering reactions on patented chips. How? We deliver any editing reagent into any cell type in low volumes, by intelligently tuning electrical parameters with a proprietary electrode configuration.
Impact that Scales
Smart Engineering
Your Partner for Personalized Discovery
FUNCTIONAL GENOMICS
Increase screen depth and donor diversity
Increase screen depth and donor diversity
Leverage genetic materials to better understand biological underpinnings of disease and identify more targets from limited sample material. DropGenie’s platform enables arrayed genetic screens that enhance discovery through the ability to compile complex array configurations and multi-parametric high throughput readouts, resulting in extremely rich data.
CELL & GENE THERAPY
Optimize Process Development
Optimize Process Development
Eliminate one of the primary barriers of CGT development–small patient population with limited sample material. Integration of the DropGenie platform into early trial design workflows enables researchers to accept large numbers of donors and screen a smaller yet deeper library to undercover potential candidates such as TCR IO and CAR-immune cells.
AI DRUG DISCOVERY
Enable functional validation at scale
Enable functional validation at scale
AI predictions are only as powerful as their validation. DropGenie generates both positive and negative functional data at scale, helping refine algorithms and confirm hits. Our platform accelerates in vitro testing of AI-driven hypotheses, enabling confident, data-rich decisions.
DropGenie in Action
Miniaturized Scalable Arrayed CRISPR Screening in Primary Cells Enables Discovery at the Single Donor Resolution
